Yesterday’s VRBPAC Meeting of the FDA.
03:17 Share

The VRBPAC of the FDA voted 17 to 4 to recommend that the FDA grant emergency use authorization to the Pfizer and biotech COVID-19 vaccine. It is expected that the FDA will do this before next week.